{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:31:44Z","timestamp":1780378304475,"version":"3.54.1"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014810","name":"Fondazione di Sardegna","doi-asserted-by":"crossref","award":["Grant ID: Prat. 2020-2197"],"award-info":[{"award-number":["Grant ID: Prat. 2020-2197"]}],"id":[{"id":"10.13039\/100014810","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The diversity in the clinical course of COVID-19 has been related to differences in innate and adaptative immune response mechanisms. Natural killer (NK) lymphocytes are critical protagonists of human host defense against viral infections. It would seem that reduced circulating levels of these cells have an impact on COVID-19 progression and severity. Their activity is strongly regulated by killer-cell immuno-globulin-like receptors (KIRs) expressed on the NK cell surface. The present study\u2019s focus was to investigate the impact of KIRs and their HLA Class I ligands on SARS-CoV-2 infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p><jats:italic>KIR<\/jats:italic> gene frequencies, <jats:italic>KIR<\/jats:italic> haplotypes, KIR ligands and combinations of KIRs and their HLA Class I ligands were investigated in 396 Sardinian patients with SARS-CoV-2 infection. Comparisons were made between 2 groups of patients divided according to disease severity: 240 patients were symptomatic or paucisymptomatic (Group A), 156 hospitalized patients had severe disease (Group S). The immunogenetic characteristics of patients were also compared to a population group of 400 individuals from the same geographical areas.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Substantial differences were obtained for <jats:italic>KIR<\/jats:italic> genes, <jats:italic>KIR<\/jats:italic> haplotypes and <jats:italic>KIR<\/jats:italic>-<jats:italic>HLA<\/jats:italic> ligand combinations when comparing patients of Group S to those of Group A. Patients in Group S had a statistically significant higher frequency of the <jats:italic>KIR<\/jats:italic> A\/A haplotype compared to patients in Group A [34.6% vs 23.8%, OR = 1.7 (95% CI 1.1\u20132.6); P = 0.02, Pc = 0.04]. Moreover, the <jats:italic>KIR2DS2<\/jats:italic>\/<jats:italic>HLA C1<\/jats:italic> combination was poorly represented in the group of patients with severe symptoms compared to those of the asymptomatic-paucisymptomatic group [33.3% vs 50.0%, OR = 0.5 (95% CI 0.3\u20130.8), P = 0.001, Pc = 0.002]. Multivariate analysis confirmed that, regardless of the sex and age of the patients, the latter genetic variable correlated with a less severe disease course [OR<jats:sub>M<\/jats:sub> = 0.4 (95% CI 0.3\u20130.7), <jats:italic>P<\/jats:italic><jats:sub><jats:italic>M<\/jats:italic><\/jats:sub> = 0.0005, <jats:italic>P<\/jats:italic><jats:sub><jats:italic>MC<\/jats:italic><\/jats:sub> = 0.005].<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The <jats:italic>KIR2DS2<\/jats:italic>\/<jats:italic>HLA C1<\/jats:italic> functional unit resulted to have a strong protective effect against the adverse outcomes of COVID-19. Combined to other well known factors such as advanced age, male sex and concomitant autoimmune diseases, this marker could prove to be highly informative of the disease course and thus enable the timely intervention needed to reduce the mortality associated with the severe forms of SARS-CoV-2 infection. However, larger studies in other populations as well as experimental functional studies will be needed to confirm our findings and further pursue the effect of KIR receptors on NK cell immune-mediated response to SARS-Cov-2 infection.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0255608","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T17:45:02Z","timestamp":1628185502000},"page":"e0255608","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-3792","authenticated-orcid":true,"given":"Roberto","family":"Littera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9474-0995","authenticated-orcid":true,"given":"Luchino","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Deidda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goffredo","family":"Angioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Cipri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Firinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Santus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Porcella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Rassu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Schirru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Cordeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Anna","family":"Kowalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ragatzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9827-2730","authenticated-orcid":true,"given":"Federica","family":"Cannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Giovanni","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Giacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Restivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Deidda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Palimodde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Congera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Perra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germano","family":"Orr\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Murru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Urru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Onali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Coghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8098-899X","authenticated-orcid":true,"given":"Andrea","family":"Perra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"pone.0255608.ref001","author":"World Health Organization","year":"2020","journal-title":"Virtual press conference on COVID-19"},{"key":"pone.0255608.ref002","first-page":"NEJMoa2023184","article-title":"Repurposed Antiviral Drugs for Covid-19\u2014Interim WHO Solidarity Trial Results","author":"WHO Solidarity Trial Consortium","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0255608.ref003","article-title":"Undetected infectives in the Covid-19 pandemic","author":"M Melis","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"5","key":"pone.0255608.ref004","doi-asserted-by":"crossref","first-page":"pii = 2000062","DOI":"10.2807\/1560-7917.ES.2020.25.5.2000062","article-title":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20\u201328 January 2020","volume":"25","author":"JA Backer","year":"2020","journal-title":"Euro Surveill"},{"issue":"3","key":"pone.0255608.ref005","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges","volume":"55","author":"CC Lai","year":"2020","journal-title":"Int J of Antimicrob Agents"},{"key":"pone.0255608.ref006","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm\u2019 in COVID-19","volume":"80","author":"Q Ye","year":"2020","journal-title":"J Infect"},{"key":"pone.0255608.ref007","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/jce.14479","article-title":"Cardiac and arrhythmic complications in patients with COVID\u201019","volume":"31","author":"AN Kochi","year":"2020","journal-title":"J of Cardiovasc Electrophysiol"},{"key":"pone.0255608.ref008","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cns.13372","article-title":"Neurological manifestations in COVID\u201019 caused by SARS\u2010CoV\u20102","volume":"26","author":"AM Baig","year":"2020","journal-title":"CNS Neurosci Ther"},{"key":"pone.0255608.ref009","article-title":"Gastrointestinal and liver manifestations in patients with COVID-19","author":"L I-Cheng","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"pone.0255608.ref010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.2020.1097","article-title":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","volume":"323","author":"AL Phelan","year":"2020","journal-title":"JAMA"},{"key":"pone.0255608.ref011","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus\u2010infected pneumonia","volume":"382","author":"Q Li","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0255608.ref012","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s13054-020-03244-3","article-title":"Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients","volume":"24","author":"A Shlomai","year":"2020","journal-title":"Crit Care"},{"key":"pone.0255608.ref013","first-page":"e23","article-title":"Understanding the T cell immune response in SARS coronavirus infection","volume":"1","author":"H-L Janice Oh","year":"2012","journal-title":"Emerg Microbes Infect"},{"key":"pone.0255608.ref014","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.3389\/fimmu.2018.02828","article-title":"Editorial: Emerging Viruses: Host Immunity and Novel Therapeutic Interventions","volume":"9","author":"A Smed-S\u00f6rensen","year":"2018","journal-title":"Front Immunol"},{"key":"pone.0255608.ref015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine Storms: Understanding COVID-19","volume":"53","author":"N Mangalmurti","year":"2020","journal-title":"Immunity"},{"key":"pone.0255608.ref016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000503030","article-title":"Innate immune evasion by human respiratory RNA viruses","volume":"12","author":"M. Kikkert","year":"2020","journal-title":"J Innate Immun"},{"key":"pone.0255608.ref017","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"CA Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"pone.0255608.ref018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"F McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"pone.0255608.ref019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"O Takeuchi","year":"2009","journal-title":"Immunol Rev"},{"key":"pone.0255608.ref020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1513\/pats.200508-090JS","article-title":"Innate immunity in the lungs","volume":"2","author":"TR Martin","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"pone.0255608.ref021","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fimmu.2016.00609","article-title":"Type-I interferon responses: from friend to foe in the battle against chronic viral infection","volume":"7","author":"A Murira","year":"2016","journal-title":"Front Immunol"},{"key":"pone.0255608.ref022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cytogfr.2014.11.003","article-title":"NK cells and interferons","volume":"26","author":"R Paolini","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"pone.0255608.ref023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"E Vivier","year":"2011","journal-title":"Science"},{"key":"pone.0255608.ref024","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2006.05.002","article-title":"Natural killer cells as an initial defense against pathogens","volume":"18","author":"MB Lodoen","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"pone.0255608.ref025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000324176","article-title":"Natural killer cell responses to viral infection","volume":"3","author":"JD Brandstadter","year":"2011","journal-title":"J Innate Immun"},{"key":"pone.0255608.ref026","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","volume":"31","author":"S Jost","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"pone.0255608.ref027","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/JVI.06209-11","article-title":"Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection","volume":"86","author":"F Li","year":"2012","journal-title":"J Virol"},{"key":"pone.0255608.ref028","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fcimb.2020.00425","article-title":"Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection","volume":"10","author":"K Frank","year":"2020","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"pone.0255608.ref029","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/infdis\/jis340","article-title":"Critical role of natural killer cells in lung immunopathology during influenza infection in mice","volume":"206","author":"MF Abdul-Careem","year":"2012","journal-title":"J Infect Dis"},{"key":"pone.0255608.ref030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/eji.201242620","article-title":"NK cells exacerbate the pathology of influenza virus infection in mice","volume":"43","author":"G Zhou","year":"2013","journal-title":"Eur J Immunol"},{"key":"pone.0255608.ref031","doi-asserted-by":"crossref","first-page":"e1007989","DOI":"10.1371\/journal.ppat.1007989","article-title":"Memory CD4 T cell-derived IL-2 synergizes with viral infection to exacerbate lung inflammation","volume":"15","author":"KK McKinstry","year":"2019","journal-title":"PLoS Pathog"},{"key":"pone.0255608.ref032","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3389\/fimmu.2019.01116","article-title":"Influenza A virus infection induces hyperresponsiveness in human lung tissue-resident and peripheral blood NK cells","volume":"10","author":"M Scharenberg","year":"2019","journal-title":"Front Immunol"},{"key":"pone.0255608.ref033","doi-asserted-by":"crossref","first-page":"733.e9","DOI":"10.1016\/j.cmi.2016.05.009","article-title":"Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection","volume":"22","author":"S Ghosh","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"pone.0255608.ref034","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.humimm.2013.05.007","article-title":"Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma","volume":"74","author":"R Littera","year":"2013","journal-title":"Hum Immunol"},{"key":"pone.0255608.ref035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1309\/WPK7Y2XKNF4CBF3R","article-title":"The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome","volume":"121","author":"National Research Project for SARS, Beijing Group","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"pone.0255608.ref036","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaci.2016.07.043","article-title":"Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69\u2013 CD56dim cells","volume":"139","author":"N Marquardt","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0255608.ref037","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"C Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"pone.0255608.ref038","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fphar.2020.01309","article-title":"Harnessing Memory NK Cell to Protect Against COVID-19","volume":"11","author":"S Soleimanian","year":"2020","journal-title":"Front Pharmacol"},{"key":"pone.0255608.ref039","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"LL Lanier","year":"2008","journal-title":"Nat Immunol"},{"key":"pone.0255608.ref040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.genom.7.080505.115726","article-title":"The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense","volume":"7","author":"AA Bashirova","year":"2006","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"pone.0255608.ref041","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","article-title":"Human diversity in killer cell inhibitory receptor genes","volume":"7","author":"M Uhrberg","year":"1997","journal-title":"Immunity"},{"key":"pone.0255608.ref042","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1034\/j.1600-065X.2001.1810113.x","article-title":"Ligands for Natural Killer cell receptors: redundancy or specificity","volume":"181","author":"A Cerwenka","year":"2001","journal-title":"Immunol Rev"},{"key":"pone.0255608.ref043","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, healthy and survival","volume":"5","author":"P. Parham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"pone.0255608.ref044","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1084\/jem.181.3.1133","article-title":"The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.","volume":"181","author":"J Gumperz","year":"1995","journal-title":"J Exp Med"},{"key":"pone.0255608.ref045","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.1301580","article-title":"Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 specificity of KIR2DS2: dominant impact of KIR2DL2\/KIR2DS2 on KIR2D NK cell repertoire formation","volume":"191","author":"G David","year":"2013","journal-title":"J Immunol"},{"key":"pone.0255608.ref046","volume-title":"Clinical management of COVID-19: interim guidance","author":"World Health Organization","year":"2020"},{"key":"pone.0255608.ref047","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1399-0039.1992.tb02041.x","article-title":"HLA structure of the Sardinian population: a haplotype study of 551 families.","volume":"40","author":"L Contu","year":"1992","journal-title":"Tissue Antigens"},{"issue":"10","key":"pone.0255608.ref048","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1101\/gr.137976.112","article-title":"Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors","volume":"22","author":"W Jiang","year":"2012","journal-title":"Genome Res"},{"key":"pone.0255608.ref049","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1034\/j.1399-0039.2002.590302.x","article-title":"Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update","volume":"59","author":"N G\u00f3mez-Lozano","year":"2002","journal-title":"Tissue Antigens"},{"key":"pone.0255608.ref050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1399-0039.2007.00923.x","article-title":"Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments","volume":"70","author":"C Vilches","year":"2007","journal-title":"Tissue Antigens"},{"key":"pone.0255608.ref051","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20051884","article-title":"Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function","volume":"203","author":"M Yawata","year":"2006","journal-title":"J Exp Med"},{"key":"pone.0255608.ref052","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.4049\/jimmunol.169.9.5118","article-title":"Killer Ig\u2010like receptor haplotype analysis by gene content: Evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets.","volume":"169","author":"KC Hsu","year":"2002","journal-title":"J Immunol"},{"key":"pone.0255608.ref053","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-065X.2006.00459.x","article-title":"KIR and disease: a model system or system of models?","volume":"214","author":"SI Khakoo","year":"2006","journal-title":"Immunol Rev"},{"key":"pone.0255608.ref054","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0198-8859(03)00067-3","article-title":"Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002","volume":"64","author":"SG Marsh","year":"2003","journal-title":"Hum Immunol"},{"key":"pone.0255608.ref055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.gene.2004.03.018","article-title":"Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B","volume":"335","author":"AM Martin","year":"2004","journal-title":"Gene"},{"key":"pone.0255608.ref056","first-page":"89","article-title":"Recombinant structures expand and contract inter and intragenic diversification at the KIR locus","volume":"14","author":"CW Pyo","journal-title":"BMC Genomics"},{"key":"pone.0255608.ref057","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fimmu.2020.00440","article-title":"Haplotype-Based Analysis of KIR-Gene Profiles in a South European Population-Distribution of Standard and Variant Haplotypes, and Identification of Novel Recombinant Structures","volume":"11","author":"E Cisneros","year":"2020","journal-title":"Front Immunol"},{"key":"pone.0255608.ref058","volume-title":"R: A Language and Environment for Statistical Computing.","author":"R Core Team","year":"2020"},{"key":"pone.0255608.ref059","doi-asserted-by":"crossref","first-page":"605688","DOI":"10.3389\/fimmu.2020.605688","article-title":"Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience","volume":"11","author":"R Littera","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"pone.0255608.ref060","doi-asserted-by":"crossref","first-page":"e47491","DOI":"10.1371\/journal.pone.0047491","article-title":"Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals","volume":"7","author":"C Vierra-Green","year":"2012","journal-title":"PLoS One"},{"key":"pone.0255608.ref061","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/vaccines8030471","article-title":"The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey","volume":"8","author":"M Noale","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"pone.0255608.ref062","doi-asserted-by":"crossref","first-page":"108016","DOI":"10.1016\/j.celrep.2020.108016","article-title":"Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.","volume":"32","author":"Y-M Liu","year":"2020","journal-title":"Cell Rep"},{"key":"pone.0255608.ref063","article-title":"COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism.","author":"L Wenzhong","year":"2020","journal-title":"ChemRxiv"},{"key":"pone.0255608.ref064","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"M Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"pone.0255608.ref065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humimm.2006.12.007","article-title":"Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and non\u2010deleted versions in different populations.","volume":"68","author":"D Middleton","year":"2007","journal-title":"Hum Immunol"},{"issue":"10","key":"pone.0255608.ref066","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fcimb.2020.00102","article-title":"Memory and Memory-Like NK Cell Responses to Microbial Pathogens","volume":"25","author":"M Brillantes","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"pone.0255608.ref067","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"C Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"pone.0255608.ref068","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fimmu.2020.01512","article-title":"Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies","volume":"11","author":"M Market","year":"2020","journal-title":"Front Immunol"},{"key":"pone.0255608.ref069","doi-asserted-by":"crossref","first-page":"e50446","DOI":"10.1371\/journal.pone.0050446","article-title":"Phenotype and functions of natural killer cells in critically-ill septic patients","volume":"7","author":"J-M Forel","year":"2012","journal-title":"PLoS One"},{"key":"pone.0255608.ref070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/imm.12854","article-title":"the biology of natural killer cells during sepsis","volume":"153","author":"Y Guo","year":"2018","journal-title":"Immunology"},{"issue":"D1","key":"pone.0255608.ref071","first-page":"D783","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools,","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0255608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T17:46:15Z","timestamp":1628185575000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0255608"}},"subtitle":[],"editor":[{"given":"Danillo G.","family":"Augusto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":71,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0255608","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]}}}